Outcomes of bedaquiline containing regimen in the treatment of adults with drug resistant tuberculosis in a tertiary care centre of Rajasthan

The emergence of drug-resistant strains of Mycobacterium tuberculosis has become a significant public health problem and has led to a setback in efforts to end tuberculosis (TB) worldwide. The longer duration, heavier pill load, and higher toxicity profile of DR-TB regimens compared to those for dr...

Full description

Bibliographic Details
Main Authors: Roshni Mary Prince, Suman Khangarot, Qazi Faizanul Haque, Anish Mittal, Ramdhan Somani, Mansha Grover
Format: Article
Language:English
Published: PAGEPress Publications 2023-08-01
Series:Monaldi Archives for Chest Disease
Subjects:
Online Access:https://monaldi-archives.org/index.php/macd/article/view/2618
_version_ 1827874945303052288
author Roshni Mary Prince
Suman Khangarot
Qazi Faizanul Haque
Anish Mittal
Ramdhan Somani
Mansha Grover
author_facet Roshni Mary Prince
Suman Khangarot
Qazi Faizanul Haque
Anish Mittal
Ramdhan Somani
Mansha Grover
author_sort Roshni Mary Prince
collection DOAJ
description The emergence of drug-resistant strains of Mycobacterium tuberculosis has become a significant public health problem and has led to a setback in efforts to end tuberculosis (TB) worldwide. The longer duration, heavier pill load, and higher toxicity profile of DR-TB regimens compared to those for drug-susceptible TB (DS-TB) lead to reduced adherence and worse treatment results, including mortality. This study was conducted to estimate treatment outcomes and adverse effects in patients with drug-resistant TB patients on bedaquiline-containing regimen. Patients after the pre-treatment evaluation were enrolled for bedaquiline-containing regimen. These patients were followed up for 18 months and the final outcome was assessed along with the adverse effects. It was found that 49 (84.4%) patients achieved culture conversion by three months and 54 (93.1%) achieved culture conversion by six months, 52 (83.81%) patients had favourable outcomes (cured, treatment completed) and 10 patients had unfavourable outcomes (died, lost to follow-up, failed). Coupled with gradually increasing trends of success rates from 2012, lesser failure rates and lesser concerns regarding grave adverse effects are a silver lining along the cloud of increasing burden and widening resistance patterns. More funding has to be directed towards ensuring adherence and finding high-risk individuals in order to expedite the achievement of sustainable development (SDG) goals.
first_indexed 2024-03-12T16:59:06Z
format Article
id doaj.art-c21d5cfcd7fa46838d9e4d420c864d39
institution Directory Open Access Journal
issn 1122-0643
2532-5264
language English
last_indexed 2024-03-12T16:59:06Z
publishDate 2023-08-01
publisher PAGEPress Publications
record_format Article
series Monaldi Archives for Chest Disease
spelling doaj.art-c21d5cfcd7fa46838d9e4d420c864d392023-08-07T18:33:33ZengPAGEPress PublicationsMonaldi Archives for Chest Disease1122-06432532-52642023-08-0110.4081/monaldi.2023.2618Outcomes of bedaquiline containing regimen in the treatment of adults with drug resistant tuberculosis in a tertiary care centre of RajasthanRoshni Mary Prince0Suman Khangarot1Qazi Faizanul Haque2Anish Mittal3Ramdhan Somani4Mansha Grover5Department of Respiratory Medicine, Government Medical College, KotaDepartment of Respiratory Medicine, Government Medical College, KotaDepartment of Respiratory Medicine, Government Medical College, KotaDepartment of Respiratory Medicine, Government Medical College, KotaDepartment of Respiratory Medicine, Government Medical College, KotaDepartment of Respiratory Medicine, Government Medical College, Kota The emergence of drug-resistant strains of Mycobacterium tuberculosis has become a significant public health problem and has led to a setback in efforts to end tuberculosis (TB) worldwide. The longer duration, heavier pill load, and higher toxicity profile of DR-TB regimens compared to those for drug-susceptible TB (DS-TB) lead to reduced adherence and worse treatment results, including mortality. This study was conducted to estimate treatment outcomes and adverse effects in patients with drug-resistant TB patients on bedaquiline-containing regimen. Patients after the pre-treatment evaluation were enrolled for bedaquiline-containing regimen. These patients were followed up for 18 months and the final outcome was assessed along with the adverse effects. It was found that 49 (84.4%) patients achieved culture conversion by three months and 54 (93.1%) achieved culture conversion by six months, 52 (83.81%) patients had favourable outcomes (cured, treatment completed) and 10 patients had unfavourable outcomes (died, lost to follow-up, failed). Coupled with gradually increasing trends of success rates from 2012, lesser failure rates and lesser concerns regarding grave adverse effects are a silver lining along the cloud of increasing burden and widening resistance patterns. More funding has to be directed towards ensuring adherence and finding high-risk individuals in order to expedite the achievement of sustainable development (SDG) goals. https://monaldi-archives.org/index.php/macd/article/view/2618tuberculosisMDR tuberculosisXDR-TBdiarylquinoline
spellingShingle Roshni Mary Prince
Suman Khangarot
Qazi Faizanul Haque
Anish Mittal
Ramdhan Somani
Mansha Grover
Outcomes of bedaquiline containing regimen in the treatment of adults with drug resistant tuberculosis in a tertiary care centre of Rajasthan
Monaldi Archives for Chest Disease
tuberculosis
MDR tuberculosis
XDR-TB
diarylquinoline
title Outcomes of bedaquiline containing regimen in the treatment of adults with drug resistant tuberculosis in a tertiary care centre of Rajasthan
title_full Outcomes of bedaquiline containing regimen in the treatment of adults with drug resistant tuberculosis in a tertiary care centre of Rajasthan
title_fullStr Outcomes of bedaquiline containing regimen in the treatment of adults with drug resistant tuberculosis in a tertiary care centre of Rajasthan
title_full_unstemmed Outcomes of bedaquiline containing regimen in the treatment of adults with drug resistant tuberculosis in a tertiary care centre of Rajasthan
title_short Outcomes of bedaquiline containing regimen in the treatment of adults with drug resistant tuberculosis in a tertiary care centre of Rajasthan
title_sort outcomes of bedaquiline containing regimen in the treatment of adults with drug resistant tuberculosis in a tertiary care centre of rajasthan
topic tuberculosis
MDR tuberculosis
XDR-TB
diarylquinoline
url https://monaldi-archives.org/index.php/macd/article/view/2618
work_keys_str_mv AT roshnimaryprince outcomesofbedaquilinecontainingregimeninthetreatmentofadultswithdrugresistanttuberculosisinatertiarycarecentreofrajasthan
AT sumankhangarot outcomesofbedaquilinecontainingregimeninthetreatmentofadultswithdrugresistanttuberculosisinatertiarycarecentreofrajasthan
AT qazifaizanulhaque outcomesofbedaquilinecontainingregimeninthetreatmentofadultswithdrugresistanttuberculosisinatertiarycarecentreofrajasthan
AT anishmittal outcomesofbedaquilinecontainingregimeninthetreatmentofadultswithdrugresistanttuberculosisinatertiarycarecentreofrajasthan
AT ramdhansomani outcomesofbedaquilinecontainingregimeninthetreatmentofadultswithdrugresistanttuberculosisinatertiarycarecentreofrajasthan
AT manshagrover outcomesofbedaquilinecontainingregimeninthetreatmentofadultswithdrugresistanttuberculosisinatertiarycarecentreofrajasthan